Izumi Iseda

505 total citations
11 papers, 345 citations indexed

About

Izumi Iseda is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Izumi Iseda has authored 11 papers receiving a total of 345 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Epidemiology, 4 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Surgery. Recurrent topics in Izumi Iseda's work include Neuroendocrine Tumor Research Advances (3 papers), Diabetes Treatment and Management (3 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Izumi Iseda is often cited by papers focused on Neuroendocrine Tumor Research Advances (3 papers), Diabetes Treatment and Management (3 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Izumi Iseda collaborates with scholars based in Japan. Izumi Iseda's co-authors include Kazuyuki Hida, Akihiro Katayama, Atsuko Nakatsuka, Sanae Teshigawara, Kazutoshi Murakami, Takahiro Terami, Hirofumi Makino, Jun Wada, Jun Eguchi and Motoko Kanzaki and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Circulation Research.

In The Last Decade

Izumi Iseda

11 papers receiving 337 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Izumi Iseda Japan 6 181 93 69 57 46 11 345
Takahiro Terami Japan 9 172 1.0× 105 1.1× 143 2.1× 61 1.1× 61 1.3× 11 477
Dorothée Thuillier France 8 175 1.0× 69 0.7× 110 1.6× 42 0.7× 115 2.5× 8 394
G. Fini Italy 13 236 1.3× 147 1.6× 166 2.4× 27 0.5× 83 1.8× 30 536
Tharini Sivasubramaniyam Canada 11 135 0.7× 129 1.4× 159 2.3× 36 0.6× 28 0.6× 18 410
Zahraa Mohammed‐Ali Canada 9 91 0.5× 71 0.8× 158 2.3× 150 2.6× 72 1.6× 13 469
Helen Tran United States 7 101 0.6× 65 0.7× 117 1.7× 41 0.7× 47 1.0× 24 347
Davide Mangiacotti Italy 7 145 0.8× 88 0.9× 89 1.3× 13 0.2× 40 0.9× 11 303
Jennifer Demieville United States 13 225 1.2× 56 0.6× 117 1.7× 37 0.6× 143 3.1× 16 523
Phaedra Tachtatzis United Kingdom 7 213 1.2× 128 1.4× 87 1.3× 34 0.6× 64 1.4× 13 390
Nicolas Gauthier France 10 107 0.6× 143 1.5× 166 2.4× 35 0.6× 63 1.4× 21 442

Countries citing papers authored by Izumi Iseda

Since Specialization
Citations

This map shows the geographic impact of Izumi Iseda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Izumi Iseda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Izumi Iseda more than expected).

Fields of papers citing papers by Izumi Iseda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Izumi Iseda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Izumi Iseda. The network helps show where Izumi Iseda may publish in the future.

Co-authorship network of co-authors of Izumi Iseda

This figure shows the co-authorship network connecting the top 25 collaborators of Izumi Iseda. A scholar is included among the top collaborators of Izumi Iseda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Izumi Iseda. Izumi Iseda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Watanabe, Mayu, Akihiro Katayama, Sanae Teshigawara, et al.. (2025). Maturity‐Onset Diabetes of the Young (MODY) With HNF1B p.Glu105Lys Mutation Achieving Significant Insulin Reduction on Tirzepatide: A Case Report. Clinical Case Reports. 13(2). e70173–e70173. 1 indexed citations
2.
3.
Katayama, Akihiro, et al.. (2021). Case of subcutaneous insulin resistance syndrome treated with ultra‐rapid insulin lispro. Journal of Diabetes Investigation. 13(3). 588–591. 5 indexed citations
4.
Inoue, Kentaro, Jun Wada, Jun Eguchi, et al.. (2013). Urinary Fetuin-A Is a Novel Marker for Diabetic Nephropathy in Type 2 Diabetes Identified by Lectin Microarray. PLoS ONE. 8(10). e77118–e77118. 49 indexed citations
5.
6.
Nakatsuka, Atsuko, Jun Wada, Izumi Iseda, et al.. (2013). Visceral Adipose Tissue-derived Serine Proteinase Inhibitor Inhibits Apoptosis of Endothelial Cells as a Ligand for the Cell-Surface GRP78/Voltage-dependent Anion Channel Complex. Circulation Research. 112(5). 771–780. 72 indexed citations
7.
Teshigawara, Sanae, Jun Wada, Kazuyuki Hida, et al.. (2012). Serum Vaspin Concentrations Are Closely Related to Insulin Resistance, and rs77060950 atSERPINA12Genetically Defines Distinct Group with Higher Serum Levels in Japanese Population. The Journal of Clinical Endocrinology & Metabolism. 97(7). E1202–E1207. 56 indexed citations
8.
Nakatsuka, Atsuko, Jun Wada, Izumi Iseda, et al.. (2012). Vaspin Is an Adipokine Ameliorating ER Stress in Obesity as a Ligand for Cell-Surface GRP78/MTJ-1 Complex. Diabetes. 61(11). 2823–2832. 108 indexed citations
9.
Katayama, Akihiro, Izumi Iseda, Atsuhito Tone, et al.. (2010). The Usefulness of Super-Selective Computed Tomography Angiography (CTA) for Diagnosing and Localizing a Small Insulinoma. Internal Medicine. 49(18). 1983–1986. 5 indexed citations
10.
Tone, Atsuhito, et al.. (2010). A Pregnant Patient with Brittle Type 1 Diabetes Successfully Managed by CSII Therapy with Insulin Aspart. Journal of Diabetes & Metabolism. 1(1). 7 indexed citations
11.
Tone, Atsuhito, et al.. (2010). A Case of Proinsulin-Secreting Malignant Insulinoma in an Elderly Patient with Cerebral Infarction. Journal of Diabetes & Metabolism. 1(1). 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takahiro Terami Breakdown of academic impact, for papers by Dorothée Thuillier Breakdown of academic impact, for papers by G. Fini Breakdown of academic impact, for papers by Tharini Sivasubramaniyam Breakdown of academic impact, for papers by Zahraa Mohammed‐Ali Breakdown of academic impact, for papers by Helen Tran Breakdown of academic impact, for papers by Davide Mangiacotti Breakdown of academic impact, for papers by Jennifer Demieville Breakdown of academic impact, for papers by Phaedra Tachtatzis Breakdown of academic impact, for papers by Nicolas Gauthier
Rankless by CCL
2026